FDA.reportPublic FDA data

carbinoxamine maleate 0.8 MG/ML Oral Solution

RxCUI
1010696
RxNorm name
carbinoxamine maleate 0.8 MG/ML Oral Solution
Display name
Carbinoxamine (Oral Liquid)
Full name
carbinoxamine maleate 0.8 MG/ML Oral Solution
Term type
SCD
Status
Active
Strength
4 mg/5ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-06-13 07:07:18

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
carbinoxamine maleate0.8 MG / 1 MLcarbinoxaminecarbinoxamine maleate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
carbinoxamine20220

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRcarbinoxamine maleate 0.8 MG/ML Oral Solution1NAMES
RxNorm Namecarbinoxamine maleate 0.8 MG/ML Oral Solution1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSCD1ATTRIBUTES
SPL_SET_ID9d11b197-cfdc-4b9b-9935-2920ccb6e5221CODES
RxCUI10106961CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
64950-243-0464950-243Carbinoxamine Maleate Carbinoxamine MaleateGenus Lifesciences Inc.ANDA040458
64950-243-1664950-243Carbinoxamine Maleate Carbinoxamine MaleateGenus Lifesciences Inc.ANDA040458

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA04045864950-243Carbinoxamine Maleate Carbinoxamine MaleateANDAGenus Lifesciences Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 33 matching rows.

NDC11, Source, Active table
NDC11SourceActive
51991033404rxnav_ndcsyes
51991033416rxnav_ndcsyes
64950024304rxnav_ndcsyes
64950024316rxnav_ndcsyes
00525675204rxnav_historical_indirect
00525675216rxnav_historical_indirect
00525675230rxnav_historical_indirect
15310011001rxnav_historical
15310011004rxnav_historical
18011067516rxnav_historical
46672064101rxnav_historical
46672064104rxnav_historical
46672064116rxnav_historical
46672064404rxnav_historical
46672064416rxnav_historical
51301018015rxnav_historical_indirect
51301018016rxnav_historical_indirect
51991022801rxnav_historical_indirect
51991022816rxnav_historical
54868501900rxnav_historical
55654003716rxnav_historical
55654004640rxnav_historical
58716041216rxnav_historical
58716041240rxnav_historical
59702004004rxnav_historical_indirect
62022025415rxnav_historical
62022025416rxnav_historical_indirect
64376061216rxnav_historical
64376061240rxnav_historical
64376070416rxnav_historical
64376071940rxnav_historical
66239019216rxnav_historical_indirect
71085008007rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CARBZAHCARBINOXAMINE MALEATEIPG Pharmaceuticals, inc.a845fc15-c675-4e33-840c-6a74e79d0ced2025-06-16Warnings, Adverse reactionsExact identifier
ndc11 (package): 71085008007
rxcui: 1010696
Carbinoxamine MaleateCARBINOXAMINE MALEATEGenus Lifesciences Inc.9d11b197-cfdc-4b9b-9935-2920ccb6e5222024-03-06Warnings, Adverse reactionsExact identifier
ndc (package): 64950-243-16
ndc (package): 64950-243-04
ndc (product): 64950-243
ndc11 (package): 64950024304
ndc11 (package): 64950024316
rxcui: 1010696

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9d11b197-cfdc-4b9b-9935-2920ccb6e522carbinoxamine maleate 4 MG in 5 mL Oral Solution [PSN] · carbinoxamine maleate 0.8 MG/ML Oral Solution [SCD] · carbinoxamine maleate 0.8 MG/ML Oral Syrup [SY] · carbinoxamine maleate 4 MG per 5 ML Oral Solution [SY]46Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20240306
a845fc15-c675-4e33-840c-6a74e79d0cedcarbinoxamine maleate 4 MG in 5 mL Oral Solution [PSN] · carbinoxamine maleate 0.8 MG/ML Oral Solution [SCD] · carbinoxamine maleate 0.8 MG/ML Oral Syrup [SY] · carbinoxamine maleate 4 MG per 5 ML Oral Solution [SY]43CARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mL20250616

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
a845fc15-c675-4e33-840c-6a74e79d0cedCARBZAH Carbinoxamine Maleate Oral Solution, 4 mg/5 mLIPG Pharmaceuticals, inc.20250616
9d11b197-cfdc-4b9b-9935-2920ccb6e522Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mLGenus Lifesciences Inc. | Mikart20240306
1edca669-8879-408a-b09c-259e363dd95cBreckenridge Pharmaceutical, Inc.20220923
748c233b-6ab9-42d0-89ab-e7ead30f7947Mikart, LLC20200521
e7d4b2a4-2dae-4026-a381-9d534d36c6b3Mikart, LLC20200408
1741b4f2-af49-43fe-8319-7b8a38fa25d2Carbinoxamine Maleate Tablets, USP 4 mg Carbinoxamine Maleate Oral Solution, 4 mg/5 mL Rx OnlyPar Pharmaceutical, Inc. | Sovereign Pharmaceuticals, LLC20180314
018249a0-b3b6-4821-a532-c4fbca3d4f1eNational Council for Prescription Drug Programs20130401
0d52a3ae-f954-4a7c-8828-a11853d4b750National Council for Prescription Drug Programs20130401
16096a5b-18fe-42ed-9a03-7c43a852c95cNational Council for Prescription Drug Programs20120724
20252c7c-7022-40b6-9f1d-927c338fd932National Council for Prescription Drug Programs20120724
48561025-bdd5-49dc-8aa2-b3442bb9dcf9National Council for Prescription Drug Programs20120724
aca6edb0-5899-44af-8d20-f37176f5ecffNational Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCR06AAAminoalkyl ethersATC1-4carbinoxamine
FDASPLN0000175587Histamine-1 Receptor AntagonistEPChas_epccarbinoxamine
FDASPLN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine
MEDRTD011725PyridinesCHEMhas_ingredientcarbinoxamine maleate
MEDRTD011725PyridinesCHEMhas_ingredientcarbinoxamine
MEDRTD000799AngioedemaDISEASEmay_treatcarbinoxamine
MEDRTD000799AngioedemaDISEASEmay_treatcarbinoxamine maleate
MEDRTD001942Breast FeedingDISEASEci_withcarbinoxamine
MEDRTD001942Breast FeedingDISEASEci_withcarbinoxamine maleate
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treatcarbinoxamine
MEDRTD003233Conjunctivitis, AllergicDISEASEmay_treatcarbinoxamine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withcarbinoxamine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withcarbinoxamine
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbinoxamine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withcarbinoxamine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbinoxamine maleate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withcarbinoxamine
MEDRTD006973HypertensionDISEASEci_withcarbinoxamine maleate
MEDRTD006973HypertensionDISEASEci_withcarbinoxamine
MEDRTD007231Infant, NewbornDISEASEci_withcarbinoxamine maleate
MEDRTD007231Infant, NewbornDISEASEci_withcarbinoxamine
MEDRTD007234Infant, PrematureDISEASEci_withcarbinoxamine maleate
MEDRTD007234Infant, PrematureDISEASEci_withcarbinoxamine
MEDRTD007415Intestinal ObstructionDISEASEci_withcarbinoxamine
MEDRTD007415Intestinal ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTD010437Peptic UlcerDISEASEci_withcarbinoxamine
MEDRTD010437Peptic UlcerDISEASEci_withcarbinoxamine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatcarbinoxamine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatcarbinoxamine maleate
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatcarbinoxamine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatcarbinoxamine maleate
MEDRTD013224Status AsthmaticusDISEASEci_withcarbinoxamine
MEDRTD013224Status AsthmaticusDISEASEci_withcarbinoxamine maleate
MEDRTD014517Ureteral ObstructionDISEASEci_withcarbinoxamine
MEDRTD014517Ureteral ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTD014524Urethral ObstructionDISEASEci_withcarbinoxamine
MEDRTD014524Urethral ObstructionDISEASEci_withcarbinoxamine maleate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moacarbinoxamine maleate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbinoxamine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacarbinoxamine maleate
MEDRTN0000008657Decreased Histamine ActivityPEhas_pecarbinoxamine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pecarbinoxamine maleate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.8 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA040458
CODESSNOMEDCT409192006
CODESVUID4032213
CODESVUID4032214
NAMESPrescribable Synonymcarbinoxamine maleate 4 MG in 5 mL Oral Solution
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File